MediKidz' haemophilia comic

Novo Nordisk sponsors haemophilia comic

pharmafile | October 7, 2011 | News story | Medical Communications Novo Nordisk, haemophilia, medical communications news 

Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK.

It features the MediKidz, a group of five superheroes from Mediland – a planet shaped like the human body.

The characters are intended to span cultures and appeal across the eight to 15 year old age group to engage with a young audience.

Novo Nordisk’s director of BioPharm Esben Bruun Mortensen said: “The comics are a useful medical educational tool and of genuine value to doctors in their clinical practice. The biggest advantage is to patients as education improves compliance with treatment.”

Advertisement

Produced by medical education publisher MediKidz, the comic will be made available to clinicians in order to help the hundreds of children with haemophilia and rare blood disorders to better understand their condition

Dr Kate Hersov, co-founder of MediKidz, said: “MediKidz is a teaching tool concept adaptable for any medical therapy and provides a unique way of teaching. The company focuses on children and was founded by doctors to explain medical topics in a way they can understand.”

Novo Nordisk currently markets the NovoSeven drug for haemophilia and has a new bleeding disorder agent, NN7415, in Phase I trials for the condition.

Dominic Tyer

Related Content

hsm_mobile_clinical_trial_istock-872676342

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis

The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as …

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation

BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of …

obesity

Pila Pharma raises SEK 20m to advance new oral obesity treatment

Swedish biotech, Pila Pharma, has raised nearly SEK 20m, equivalent to €1.7m in a capital …

The Gateway to Local Adoption Series

Latest content